---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-015389"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T23:09:27.005700+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals appoints Amanda Hammer as COO; CEO salary raised to $300k

## Summary
- Amanda Hammer appointed COO effective May 1, 2023; replaces Jonathan Arango who remains President/Secretary/Board member.
- COO receives $150k annual salary, 75k vested common shares, and options for 150k shares at $1.10 strike.
- CEO Jacob Cohen's salary increased from $180k to $300k per year, effective May 1, 2023.
- Hammer previously served as director of e-Commerce since Oct 2022; prior COO at D Magazine Partners.

## SEC filing metadata
- accession: 0001493152-23-015389
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/0001493152-23-015389-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-015389
- JSON: https://secwatch.observer/filing/0001493152-23-015389.json
- Plain text: https://secwatch.observer/filing/0001493152-23-015389.txt

## Key facts
- Executive change
  Amanda Hammer was appointed as Chief Operating Officer at MANGOCEUTICALS, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: Effective on May 1, 2023, the Board of Directors of Mangoceuticals, Inc. (the “ Company ”, “ we ” and “ us ”) appointed Mrs. Amanda Hammer, as the Chief Operating Officer (COO) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/0001493152-23-015389-index.htm
- Executive change
  Jonathan Arango changed role as Chief Operating Officer at MANGOCEUTICALS, INC..
  - Action: ceased serving as
  - Role: Chief Operating Officer
  source text: As a result of such appointment Jonathan Arango, the President, Secretary and member of the Board of Directors of the Company, ceased serving as COO, but will continue serving in his other roles with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1938046/000149315223015389/0001493152-23-015389-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.